Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$1.04B |
| 2 |
GE Vernova
GEV
|
+$497M |
| 3 |
ExxonMobil
XOM
|
+$475M |
| 4 |
ResMed
RMD
|
+$398M |
| 5 |
International Paper
IP
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$887M |
| 2 |
Microsoft
MSFT
|
+$697M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$558M |
| 4 |
Waters Corp
WAT
|
+$422M |
| 5 |
AbbVie
ABBV
|
+$382M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.32% |
| 2 | Healthcare | 11.76% |
| 3 | Financials | 11.45% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Trevi Therapeutics
TRVI
$2.53B
| $532K | ﹤0.01% |
178,511
+49,884
| +39% | +$139K |
|
|
ESSA
3502
DELISTED
ESSA Bancorp
ESSA
| $530K | ﹤0.01% |
30,115
+977
| +3% | +$16.6K |
|
3503
Cibus
CBUS
$145M
| $529K | ﹤0.01% |
+53,662
| New | +$811K |
|
|
EIM
3504
Eaton Vance Municipal Bond Fund
EIM
$497M
| $528K | ﹤0.01% |
49,895
+1,073
| +2% | +$11.1K |
|
|
GBIO
3505
DELISTED
Generation Bio
GBIO
| $527K | ﹤0.01% |
18,676
+4,438
| +31% | +$144K |
|
3506
Blackstone Secured Lending
BXSL
$5.69B
| $525K | ﹤0.01% |
17,144
+1,474
| +9% | +$46.1K |
|
3507
PUT
Marvell Technology
MRVL
$199B
| $524K | ﹤0.01% |
7,500
| – | – |
|
3508
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.29B
| $523K | ﹤0.01% |
29,622
-4,651
| -14% | -$82.1K |
|
|
PARAA
3509
DELISTED
Paramount Global Class A
PARAA
| $520K | ﹤0.01% |
28,315
+3,281
| +13% | +$69.3K |
|
|
NAGE
3510
Niagen Bioscience
NAGE
$242M
| $520K | ﹤0.01% |
190,442
+119,915
| +170% | +$401K |
|
3511
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $518K | ﹤0.01% |
5,590
+744
| +15% | +$66.7K |
|
3512
Goldman Sachs Access Inflation Protected USD Bond ETF
GTIP
$296M
| $518K | ﹤0.01% |
10,677
-139
| -1% | -$6.72K |
|
3513
INmune Bio
INMB
$56.6M
| $517K | ﹤0.01% |
58,600
+32,511
| +125% | +$320K |
|
3514
Abeona Therapeutics
ABEO
$425M
| $515K | ﹤0.01% |
121,453
+2,434
| +2% | +$12.4K |
|
|
BLE
3515
DELISTED
BlackRock Municipal Income Trust II
BLE
| $513K | ﹤0.01% |
47,444
+945
| +2% | +$9.97K |
|
|
MFM
3516
Aberdeen Municipal Income Fund
MFM
$223M
| $512K | ﹤0.01% |
93,724
-4,641
| -5% | -$24.2K |
|
3517
Redwire
RDW
$3.3B
| $512K | ﹤0.01% |
71,340
+59,372
| +496% | +$286K |
|
3518
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
$3.87B
| $510K | ﹤0.01% |
21,506
+7,279
| +51% | +$172K |
|
3519
Lexeo Therapeutics
LXEO
$400M
| $510K | ﹤0.01% |
31,806
+3,483
| +12% | +$50.6K |
|
3520
Cerence
CRNC
$391M
| $510K | ﹤0.01% |
180,171
-299,903
| -62% | -$2.14M |
|
3521
Accuray
ARAY
$32.9M
| $509K | ﹤0.01% |
279,426
+8,864
| +3% | +$16.9K |
|
3522
Black Diamond Therapeutics
BDTX
$121M
| $508K | ﹤0.01% |
+108,959
| New | +$585K |
|
3523
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$271M
| $507K | ﹤0.01% |
27,393
-8,168
| -23% | -$151K |
|
|
FSCO
3524
FS Credit Opportunities Corp
FSCO
$1.03B
| $507K | ﹤0.01% |
79,570
+3,662
| +5% | +$22.5K |
|
3525
Caribou Biosciences
CRBU
$160M
| $506K | ﹤0.01% |
308,273
+38,098
| +14% | +$122K |
|
Similar funds
Bank of New York Mellon's Q2 2024 Portfolio in Review
As of Q2 2024, Bank of New York Mellon held 4,366 positions worth $528B, up 1.3% from $521B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q2 2024 filing shows 216 new, 2,305 increased, 1,454 reduced and 245 closed positions. Its largest new stake was GE Vernova: 3,134,941 shares worth $538M. The largest sale was NVIDIA, an estimated $887M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2024 buy was GE Vernova: 3,134,941 shares worth $538M.
- Bank of New York Mellon added most to Ferguson in Q2 2024, an estimated $1.04B increase.
- Bank of New York Mellon's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $887M.
- Bank of New York Mellon fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $558M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $528B portfolio in Q2 2024.
- Bank of New York Mellon opened 216 new positions and closed 245 in Q2 2024.
- Bank of New York Mellon's portfolio value rose 1.3% quarter-over-quarter to $528B.
Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.